ABOUT

Merlin Biotech – advancing new therapies

Merlin Biotech leverages the proven mRNA technology to develop novel therapeutics that address important unmet medical needs like adult and pediatric cancers.

OUR MANAGEMENT TEAM

Merlin’s leadership and boards include a former Moderna Senior VP, a Nobel Laureate, and global experts in mRNA development and oncology.

VIEW THE FULL TEAM
Randall N. Hyer, MD, PhD, MPH

Randall N. Hyer, MD, PhD, MPH

Chief Executive Officer

VIEW PROFILE
Ian Henrich, PhD

Ian Henrich, PhD

Vice President, Research
and Development

VIEW PROFILE
Nick Spring, DipM, MCIM

Nick Spring, DipM, MCIM

Business Strategy & Commercialization

VIEW PROFILE
Yolanda Sanchez, PhD, MS

Yolanda Sanchez, PhD, MS

Clinical Study Design & Drug Development

VIEW PROFILE